Road to Commercialization Symposium Series: Commercialization Pathways for Basic and Applied Research

Join us for the next webinar of the Road to Commercialization Symposium Series!

The topic: Communicating with Impact and the Art of Storytelling

Research, both basic and applied, can be commercialized. However, there is no single path to commercialization. Hear from experts about their entrepreneurial journeys and the tools and resources available to you as you strive to impact the world with your discoveries.

PANELISTS

RICHARD RIMAN, PHD
Distinguished Professor of Materials Science and Engineering, Rutgers
Academic Lead, Queens Carbon

Riman is a Distinguished Professor of Materials Science & Engineering at Rutgers University for more than 30 years. He has a passion for inventing solutions to some of the world's biggest climate issues, and has founded or co-founded multiple startups including Solidia, RRTC, and Queens Carbon.

DANIEL KOPP, PHD
CEO/CTO and Co-Founder, Queens Carbon

One of the co-founders of Queens Carbon, Kopp received his PhD in Materials Science & Engineering from Rutgers University with a focus on hydrothermal processing, CCUS, and inorganic material synthesis.

RENATA PASQUALINI, PHD
Professor, Rutgers Cancer Institute of New Jersey
Chief, Division of Cancer Biology at Rutgers New Jersey Medical School
Co-Founder, MBrace Therapeutics
Co-Founder and CSO, PhageNova Bio

Pasqualini is a professor of medicine and Chief of the Division of Cancer Biology at CINJ/Rutgers University. She received her PhD from the Ludwig Institute for Cancer Research and has co-founded two startups, MBrace Therapeutics and PhageNova Bio.